1944 HADDOW, Sir Alexander (1907 – 1976); ET AL

Influence of synthetic oestrogens upon advanced malignant disease.

Administration of synthetic estrogens in advanced mammary cancer caused regression of tumors. With J. M. Watkinson, E. Paterson, and P. C. Koller.

GMN 2659.3 · https://historyofmedicine.com/id/3355

1948 FARBER, Sidney (1903 – 1973)

Temporary remissions in acute leukemia in children produced by folic acid antagonist 4-amethopteroylglutamic acid (aminopterin).

With L. K. Diamond, R. D. Mercer, R. F. Sylvester, and V. A. Wolff.

GMN 2660.1 · https://historyofmedicine.com/id/3370

1958 ARNOLD, Herbert; ET AL

Neuartige Krebs-Chemotherapeutica aus der Gruppe der zyklischen N-Lost-Phosphamidester.

Cyclophosphamide. With F. Bourseaux and N. Brock.

GMN 2660.11 · https://historyofmedicine.com/id/3395

1963 BROOME, John Denis

Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects.

GMN 2660.14 · https://historyofmedicine.com/id/3400

1963 JOHNSON, Irving Stanley (1925 – 2014); ET AL

The Vinca alkaloids: a new class of oncolytic agents.

Clinical use of vinblastine (for Hodgkin’s disease and other lymphomas) and vincristine (for acute leukemias of childhood). With J. G. Armstrong, M. Gorman, and J. P. Burnett. Preliminary communication in J. Lab. clin…

GMN 2660.16 · https://historyofmedicine.com/id/3406